171 related articles for article (PubMed ID: 35148019)
1. The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins.
Cao S; Zhang M; Yuan M; Yang D; Zhao M; Zhang S; Wang P; Zhang R; Gao X
Pharmacol Res Perspect; 2022 Feb; 10(1):e00928. PubMed ID: 35148019
[TBL] [Abstract][Full Text] [Related]
2. Effect of polyethylene glycol 400 on the pharmacokinetics and tissue distribution of baicalin by intravenous injection based on the enzyme activity of UGT1A8/1A9.
Shang LY; Zhou MH; Cao SY; Zhang M; Wang PJ; Zhang S; Meng XX; Yang QM; Gao XL
Eur J Pharm Sci; 2023 Jan; 180():106328. PubMed ID: 36379359
[TBL] [Abstract][Full Text] [Related]
3. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
[TBL] [Abstract][Full Text] [Related]
4. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2.
Akao T; Hanada M; Sakashita Y; Sato K; Morita M; Imanaka T
J Pharm Pharmacol; 2007 Jan; 59(1):87-93. PubMed ID: 17227625
[TBL] [Abstract][Full Text] [Related]
5. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein.
Zhang L; Lin G; Zuo Z
Pharm Res; 2007 Jan; 24(1):81-9. PubMed ID: 17109214
[TBL] [Abstract][Full Text] [Related]
6. Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.
Zhang Y; Zhang M; Hu G; Zhang Z; Song R
J Ethnopharmacol; 2020 Mar; 250():112528. PubMed ID: 31884038
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic study on the intestinal absorption and disposition of baicalein.
Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
[TBL] [Abstract][Full Text] [Related]
8. Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.
Li Y; Lu L; Wang L; Qu W; Liu W; Xie Y; Zheng H; Wang Y; Qi X; Hu M; Zhu L; Liu Z
Mol Pharm; 2018 Dec; 15(12):5602-5614. PubMed ID: 30376625
[TBL] [Abstract][Full Text] [Related]
9. Role of intestinal first-pass metabolism of baicalein in its absorption process.
Zhang L; Lin G; Chang Q; Zuo Z
Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
[TBL] [Abstract][Full Text] [Related]
10. Oral pharmacokinetics of baicalin, wogonoside, oroxylin A 7-O-β-d-glucuronide and their aglycones from an aqueous extract of Scutellariae Radix in the rat.
Cai Y; Li S; Li T; Zhou R; Wai AT; Yan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():124-133. PubMed ID: 26809374
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species.
Zhang R; Cui Y; Wang Y; Tian X; Zheng L; Cong H; Wu B; Huo X; Wang C; Zhang B; Wang X; Yu Z
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):981-992. PubMed ID: 28536775
[TBL] [Abstract][Full Text] [Related]
12. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.
Jiang W; Xu B; Wu B; Yu R; Hu M
Drug Metab Dispos; 2012 Feb; 40(2):336-45. PubMed ID: 22071170
[TBL] [Abstract][Full Text] [Related]
13. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
14. Baicalein 6-O-β-D-glucopyranuronoside is a main metabolite in the plasma after oral administration of baicalin, a flavone glucuronide of scutellariae radix, to rats.
Akao T; Sato K; He JX; Ma CM; Hattori M
Biol Pharm Bull; 2013; 36(5):748-53. PubMed ID: 23649334
[TBL] [Abstract][Full Text] [Related]
15. Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.
Qi C; Fu J; Zhao H; Xing H; Dong D; Wu B
Xenobiotica; 2019 Mar; 49(3):276-283. PubMed ID: 29436891
[TBL] [Abstract][Full Text] [Related]
16. An Agent-Based Approach to Dynamically Represent the Pharmacokinetic Properties of Baicalein.
Zhu X; Deng J; Zuo Z; Lam TN
AAPS J; 2016 Nov; 18(6):1475-1488. PubMed ID: 27480317
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus L.).
Nikolic D; Li Y; Chadwick LR; van Breemen RB
Pharm Res; 2006 May; 23(5):864-72. PubMed ID: 16715376
[TBL] [Abstract][Full Text] [Related]
18. [Effect of PEG400 on pharmacokinetics of baicalin and baicalein in gut microbiotadysbiosis rats].
Gu T; Zhang S; Zhang M; Meng XX; Gao XL
Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(5):1034-1040. PubMed ID: 30989866
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inhibitors of intestinal UDP-glucuronosyltransferases 1A8 and 1A10 using raloxifene as a substrate in Caco-2 cells: Studies with four flavonoids of Scutellaria baicalensis.
Chang CF; Chang YC; Lin JT; Yu CW; Kao YT
Toxicol In Vitro; 2021 Apr; 72():105087. PubMed ID: 33440186
[TBL] [Abstract][Full Text] [Related]
20. Cellular asymmetric catalysis by UDP-glucuronosyltransferase 1A8 shows functional localization to the basolateral plasma membrane.
Ziegler K; Tumova S; Kerimi A; Williamson G
J Biol Chem; 2015 Mar; 290(12):7622-33. PubMed ID: 25586184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
